PIA-PR 2025-2026 Board of Directors
PIA’s Board of Directors is composed of 10 members represented by the company’s top executive in Puerto Rico. Five members represent the manufacturing sector and five the commercial sector. In addition, there are three ex-officio members: The Operations Director, the legal Counsel, and the Advisor to the Board.
The Executive Committee of the board is composed by:
Executive Commitee
Juan I. Diddi
Chairperson
General Manager Puerto Rico & Caribe
Bristol Myers Squibb
David L. Thompson
Vice Chairperson
Site Head
AbbVie
Glorimar Torres
Secretary
General Manager
Amgen Commercial Operations
Brandon P. Paschal
Treasurer
SVP Global Dry Products Operations, President & GM
Lilly del Caribe
Directors
José Castellote is General Manager of J&J Innovative Medicines
José Castellote
General Manager J&J Innovative Medicines
Javier F. Deida is Regional Business director and Country Lead of Pfizer Biopharmaceuticals
Javier F. Deida
Regional Business director and Country Lead Pfizer Biopharmaceuticals
Sara M. Miranda is President & General Manager of AstraZeneca Operations/IPR Pharmaceuticals
Sara Miranda
President & General Manager AstraZeneca Operations/IPR Pharmaceuticals
Iramis Ralat is Executive Director & General Manager of Bristol Myers Squibb
Iramis Ralat
Executive Director & General Manager Bristol Myers Squibb
María M. Rivera is Business Director Puerto Rico Market of Organon
María M. Rivera
Business Director Puerto Rico Market Organon
Thomas Seewoester is VP Site Operations of Amgen Manufacturing Limited
Thomas Seewoester
VP Site Operations Amgen Manufacturing Limited
Past President
Ileana Quiñones is VP & General Manager of J&J Innovative Medicines Supply
Ileana Quiñones
VP & General Manager J&J Innovative Medicines Supply
Ad Hoc Members
Rafael Castro
VP Operations
Iván Román
Advisor to the Board
Eduardo Negrón Navas
Legal Counsel
